Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 17Ovarian Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Lung Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor - Protocol Specific 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hypertension 1Glioblastoma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 38Paclitaxel 22Epirubicin 21Trastuzumab 20Docetaxel 20Doxorubicin 19Carboplatin 15Radiotherapy 13Taxes 11Filgrastim 11Neoadjuvant Therapy 9Bevacizumab 9Fluorouracil 8pembrolizumab 7Tamoxifen 7Albumin-Bound Paclitaxel 7Capecitabine 6pertuzumab 5Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Lapatinib 5130-nm albumin-bound paclitaxel 5pegfilgrastim 4Granulocyte Colony-Stimulating Factor 4Cisplatin 4Chemotherapy, Adjuvant 4Biopsy 4tipifarnib 3eribulin 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × pazopanib × Breast × Clear all
NCT00558103 2013-02-04

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

GlaxoSmithKline

Phase 2 Completed
163 enrolled 14 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡